UniProt ID | EPHA2_MOUSE | |
---|---|---|
UniProt AC | Q03145 | |
Protein Name | Ephrin type-A receptor 2 | |
Gene Name | Epha2 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 977 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein . Cell projection, ruffle membrane Single-pass type I membrane protein . Cell projection, lamellipodium membrane Single-pass type I membrane protein . Cell junction, focal adhesion . Present at |
|
Protein Description | Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Activated by the ligand ephrin-A1/EFNA1 regulates migration, integrin-mediated adhesion, proliferation and differentiation of cells. Regulates cell adhesion and differentiation through DSG1/desmoglein-1 and inhibition of the ERK1/ERK2 signaling pathway. May also participate in UV radiation-induced apoptosis and have a ligand-independent stimulatory effect on chemotactic cell migration. During development, may function in distinctive aspects of pattern formation and subsequently in development of several fetal tissues. Involved for instance in angiogenesis, in early hindbrain development and epithelial proliferation and branching morphogenesis during mammary gland development. Engaged by the ligand ephrin-A5/EFNA5 may regulate lens fiber cells shape and interactions and be important for lens transparency development and maintenance. With ephrin-A2/EFNA2 may play a role in bone remodeling through regulation of osteoclastogenesis and osteoblastogenesis.. | |
Protein Sequence | MELRAVGFCLALLWGCALAAAAAQGKEVVLLDFAAMKGELGWLTHPYGKGWDLMQNIMDDMPIYMYSVCNVVSGDQDNWLRTNWVYREEAERIFIELKFTVRDCNSFPGGASSCKETFNLYYAESDVDYGTNFQKRQFTKIDTIAPDEITVSSDFEARNVKLNVEERMVGPLTRKGFYLAFQDIGACVALLSVRVYYKKCPEMLQSLARFPETIAVAVSDTQPLATVAGTCVDHAVVPYGGEGPLMHCTVDGEWLVPIGQCLCQEGYEKVEDACRACSPGFFKSEASESPCLECPEHTLPSTEGATSCQCEEGYFRAPEDPLSMSCTRPPSAPNYLTAIGMGAKVELRWTAPKDTGGRQDIVYSVTCEQCWPESGECGPCEASVRYSEPPHALTRTSVTVSDLEPHMNYTFAVEARNGVSGLVTSRSFRTASVSINQTEPPKVRLEDRSTTSLSVTWSIPVSQQSRVWKYEVTYRKKGDANSYNVRRTEGFSVTLDDLAPDTTYLVQVQALTQEGQGAGSKVHEFQTLSTEGSANMAVIGGVAVGVVLLLVLAGVGLFIHRRRRNLRARQSSEDVRFSKSEQLKPLKTYVDPHTYEDPNQAVLKFTTEIHPSCVARQKVIGAGEFGEVYKGTLKASSGKKEIPVAIKTLKAGYTEKQRVDFLSEASIMGQFSHHNIIRLEGVVSKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIASGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSYGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERSRRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSGSEGVPFRTVSEWLESIKMQQYTEHFMVAGYTAIEKVVQMSNEDIKRIGVRLPGHQKRIAYSLLGLKDQVNTVGIPI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
106 | Phosphorylation | FTVRDCNSFPGGASS EEEEECCCCCCCHHC | 38.87 | 28576409 | |
112 | Phosphorylation | NSFPGGASSCKETFN CCCCCCHHCCHHHEE | 39.27 | 22817900 | |
113 | Phosphorylation | SFPGGASSCKETFNL CCCCCHHCCHHHEEE | 28.77 | 22817900 | |
152 | Phosphorylation | APDEITVSSDFEARN CCCEEEECCCCHHCC | 18.62 | 26824392 | |
305 | Ubiquitination | TLPSTEGATSCQCEE CCCCCCCCCCCCCCC | 7.07 | 27667366 | |
364 | Phosphorylation | GRQDIVYSVTCEQCW CCCEEEEEEEECCCC | 10.47 | 23984901 | |
366 | Phosphorylation | QDIVYSVTCEQCWPE CEEEEEEEECCCCCC | 12.37 | 23984901 | |
374 | Phosphorylation | CEQCWPESGECGPCE ECCCCCCCCCCCCCE | 35.49 | 27087446 | |
383 | Phosphorylation | ECGPCEASVRYSEPP CCCCCEEEEECCCCC | 5.71 | 23984901 | |
408 | N-linked_Glycosylation | SDLEPHMNYTFAVEA HHCCCCCCEEEEEEE | 29.65 | 19656770 | |
436 | N-linked_Glycosylation | RTASVSINQTEPPKV EEEEEEECCCCCCEE | 34.90 | 19656770 | |
571 | Phosphorylation | RNLRARQSSEDVRFS HHHHHHCCCCCCCCC | 30.09 | 27087446 | |
572 | Phosphorylation | NLRARQSSEDVRFSK HHHHHCCCCCCCCCH | 29.49 | 24453211 | |
578 | Phosphorylation | SSEDVRFSKSEQLKP CCCCCCCCHHHCCCC | 25.38 | 26824392 | |
579 | Ubiquitination | SEDVRFSKSEQLKPL CCCCCCCHHHCCCCC | 56.13 | 22790023 | |
580 | Phosphorylation | EDVRFSKSEQLKPLK CCCCCCHHHCCCCCC | 29.40 | 22499769 | |
584 | Ubiquitination | FSKSEQLKPLKTYVD CCHHHCCCCCCEECC | 48.26 | 22790023 | |
588 | Phosphorylation | EQLKPLKTYVDPHTY HCCCCCCEECCCCCC | 36.14 | 22499769 | |
589 | Phosphorylation | QLKPLKTYVDPHTYE CCCCCCEECCCCCCC | 10.98 | 25521595 | |
594 | Phosphorylation | KTYVDPHTYEDPNQA CEECCCCCCCCCCCH | 33.71 | 22499769 | |
595 | Phosphorylation | TYVDPHTYEDPNQAV EECCCCCCCCCCCHH | 18.46 | 25521595 | |
604 | Ubiquitination | DPNQAVLKFTTEIHP CCCCHHHEEECEECH | 33.78 | 22790023 | |
609 | Ubiquitination | VLKFTTEIHPSCVAR HHEEECEECHHHHHH | 5.63 | 27667366 | |
618 | Ubiquitination | PSCVARQKVIGAGEF HHHHHHCEEECCCCC | 30.21 | 22790023 | |
629 | Phosphorylation | AGEFGEVYKGTLKAS CCCCCEEEEEEEECC | 10.21 | 29514104 | |
632 | Phosphorylation | FGEVYKGTLKASSGK CCEEEEEEEECCCCC | 22.42 | 17242355 | |
648 | Phosphorylation | EIPVAIKTLKAGYTE CCCEEEEEECCCCCH | 27.64 | - | |
736 | Phosphorylation | KYLANMNYVHRDLAA HHHHCCCCCCHHHHH | 6.20 | 18387945 | |
762 | Phosphorylation | KVSDFGLSRVLEDDP EECHHCCCHHCCCCC | 22.26 | 20415495 | |
772 | Phosphorylation | LEDDPEATYTTSGGK CCCCCCCEEECCCCE | 21.53 | 26239621 | |
773 | Phosphorylation | EDDPEATYTTSGGKI CCCCCCEEECCCCEE | 18.31 | 25521595 | |
774 | Phosphorylation | DDPEATYTTSGGKIP CCCCCEEECCCCEEE | 15.32 | 22499769 | |
775 | Phosphorylation | DPEATYTTSGGKIPI CCCCEEECCCCEEEE | 18.24 | 22499769 | |
776 | Phosphorylation | PEATYTTSGGKIPIR CCCEEECCCCEEEEE | 37.44 | 22499769 | |
791 | Phosphorylation | WTAPEAISYRKFTSA EECCCCCCCCCCCCH | 26.40 | 25263469 | |
870 | Phosphorylation | PKFADIVSILDKLIR CCHHHHHHHHHHHHC | 20.12 | - | |
874 | Ubiquitination | DIVSILDKLIRAPDS HHHHHHHHHHCCCCH | 42.22 | - | |
883 | Ubiquitination | IRAPDSLKTLADFDP HCCCCHHHCCCCCCC | 45.50 | 22790023 | |
893 | Phosphorylation | ADFDPRVSIRLPSTS CCCCCCEEEECCCCC | 11.85 | 26824392 | |
898 | Phosphorylation | RVSIRLPSTSGSEGV CEEEECCCCCCCCCC | 39.53 | 27087446 | |
899 | Phosphorylation | VSIRLPSTSGSEGVP EEEECCCCCCCCCCC | 34.86 | 27087446 | |
900 | Phosphorylation | SIRLPSTSGSEGVPF EEECCCCCCCCCCCC | 44.66 | 26824392 | |
902 | Phosphorylation | RLPSTSGSEGVPFRT ECCCCCCCCCCCCEE | 30.83 | 27087446 | |
922 | Phosphorylation | ESIKMQQYTEHFMVA HHHHHHHCHHHHHHH | 9.37 | 22499769 | |
923 | Phosphorylation | SIKMQQYTEHFMVAG HHHHHHCHHHHHHHH | 20.74 | 22499769 | |
931 | Phosphorylation | EHFMVAGYTAIEKVV HHHHHHHHHHHHHHH | 5.35 | 22499769 | |
932 | Phosphorylation | HFMVAGYTAIEKVVQ HHHHHHHHHHHHHHH | 21.90 | 22499769 | |
941 | Phosphorylation | IEKVVQMSNEDIKRI HHHHHHCCHHHHHHH | 21.70 | 26824392 | |
961 | Phosphorylation | GHQKRIAYSLLGLKD CHHHHHHHHHCCCCC | 9.47 | 17242355 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EPHA2_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-408 AND ASN-436, AND MASSSPECTROMETRY. | |
"The mouse C2C12 myoblast cell surface N-linked glycoproteome:identification, glycosite occupancy, and membrane orientation."; Gundry R.L., Raginski K., Tarasova Y., Tchernyshyov I.,Bausch-Fluck D., Elliott S.T., Boheler K.R., Van Eyk J.E.,Wollscheid B.; Mol. Cell. Proteomics 8:2555-2569(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-408 AND ASN-436, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry."; Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.; Mol. Cell. Proteomics 8:904-912(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-595 AND TYR-773, ANDMASS SPECTROMETRY. | |
"Identification and functional analysis of phosphorylated tyrosineresidues within EphA2 receptor tyrosine kinase."; Fang W.B., Brantley-Sieders D.M., Hwang Y., Ham A.-J.L., Chen J.; J. Biol. Chem. 283:16017-16026(2008). Cited for: IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, INTERACTION WITH VAV2;VAV3 AND PI3-KINASE P85 SUBUNIT, PHOSPHORYLATION AT TYR-589; TYR-595;TYR-736 AND TYR-773, AND MUTAGENESIS OF TYR-589; TYR-595; TYR-736;TYR-773 AND TYR-931. |